Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s295, 2023. DOI: 10.25251/skin.7.supp.295. Disponível em: https://skin.dermsquared.com/skin/article/view/2381. Acesso em: 20 apr. 2026.